ArticleInternational orthopaedics2026
Risk of Ossification of the Posterior Longitudinal Ligament (OPLL) following gout diagnosis: a nationwide cohort study.
Article in International orthopaedics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
- Commented on by
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
STUDY
designPopulation-based retrospective cohort study.
objectivesTo assess the longitudinal association between incident gout and risk of incident cervical ossification of the posterior longitudinal ligament (OPLL).
methodsUsing National Health Insurance Service data linked to health screening records (2002-2013), adults aged 20-79 years with incident gout were identified (≥ 2 primary diagnoses of ICD-10 M10.0/M10.9 within 30 days) after a two year washout. Controls without gout were propensity score-matched 1:20. Incident cervical OPLL was defined as ICD-10 M48.82 with cervical CT or MRI within 30 days. Participants were followed from index date to OPLL, death, or December 31, 2013. Cox proportional hazards models estimated adjusted hazard ratios (HRs); sensitivity analyses used a stricter OPLL definition (≥ 2 diagnoses > 30 days apart).
resultsThe matched cohort included 5,977 gout patients and 119,540 controls (478,828 person-years). OPLL developed in 17 (0.28%) gout patients versus 162 (0.14%) controls, yielding incidence rates of 0.75 vs 0.36 per 1,000 person-years (incidence rate ratio 2.11; 95% CI, 1.28-3.47). Gout was associated with increased OPLL risk in the fully adjusted model (HR 2.13; 95% CI, 1.27-3.56). Findings were consistent under the stricter definition (incidence rate ratio 2.29; 95% CI, 1.26-4.17).
conclusionsIn this nationwide cohort, incident gout was independently associated with more than a twofold higher risk of incident cervical OPLL.
Indexed as
Identifiers
41915154What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.